Expression changes and novel interaction partners of talin 1 in effector cells of autoimmune uveitis.

This research paper is about identifying new interaction partners of a protein called talin 1, specifically in the context of autoimmune uveitis (an inflammation of the eye often linked to autoimmune diseases), by using the naturally occurring model of the disease in horses.

Research Context

• The researchers focused on autoimmune uveitis, a type of inflammation of the eye that occurs when the immune system attacks the body’s own cells. This condition is often characterized by the blood-retinal barrier (BRB) being crossed by aggressive immune cells.
• The study used equine recurrent uveitis (ERU) as a spontaneous model for studying the condition. ERU is a recurrent inflammation of the uveal tract in horses that shares many clinical and pathological similarities with human autoimmune uveitis.
• In healthy eyes, there are typically no leukocytes (white blood cells involved in protecting the body against both infectious disease and foreign invaders). However, in ERU, leukocytes infiltrate the inner eye, causing destruction.

Research Aim and Method

• The researchers aimed to uncover the molecular mechanisms that allow leukocytes to cross the BRB. Specifically, they looked at talin 1, a protein they previously found to be expressed less in the blood-derived granulocytes (a type of white blood cell) of horses with ERU.
• They hypothesized that changes in the protein expression pattern of leukocytes might contribute to the ability of these cells to migrate, a key pathological feature of ERU.
• To identify proteins that interact with talin 1 in leukocytes, they used a technique called immunoprecipitation, followed by liquid chromatography tandem mass spectrometry (LC-MS/MS), a method used for identifying and quantifying proteins.

Key Findings

• The researchers identified a new interaction partner of talin 1: CD90, also known as Thy1. This protein was found to be highly abundant in granulocytes from healthy individuals but significantly reduced in ERU, especially in effector cells.
• They also identified several other proteins that interact with talin 1 in leukocytes although they did not elaborate on these in the abstract.
• The study points to a connection between talin 1 and CD90 and their differential expression during inflammation. This findings provide a deeper understanding of the immune response in ERU, particularly in relation to the migration ability of granulocytes.

Implications

• This research offers new insights into the mechanisms that underpin leukocyte migration in autoimmune uveitis. The identification of new interaction partners of talin 1, like CD90, could potentially open up novel avenues for the development of therapies targeting these proteins.
• The study also underscores the use of equine models in studying human autoimmune uveitis, which could be a promising approach in future research.